6-136191810-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_018945.4(PDE7B):āc.1323G>Cā(p.Glu441Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000623 in 1,556,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018945.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDE7B | NM_018945.4 | c.1323G>C | p.Glu441Asp | missense_variant | 13/13 | ENST00000308191.11 | NP_061818.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDE7B | ENST00000308191.11 | c.1323G>C | p.Glu441Asp | missense_variant | 13/13 | 1 | NM_018945.4 | ENSP00000310661 | P1 | |
PDE7B-AS1 | ENST00000655618.1 | n.82-29462C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152244Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000870 AC: 14AN: 161004Hom.: 0 AF XY: 0.000117 AC XY: 10AN XY: 85404
GnomAD4 exome AF: 0.0000577 AC: 81AN: 1403856Hom.: 0 Cov.: 31 AF XY: 0.0000678 AC XY: 47AN XY: 693152
GnomAD4 genome AF: 0.000105 AC: 16AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.1323G>C (p.E441D) alteration is located in exon 13 (coding exon 13) of the PDE7B gene. This alteration results from a G to C substitution at nucleotide position 1323, causing the glutamic acid (E) at amino acid position 441 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at